Inventor · disambiguated record
John J. Kopchick
Also filed as: KOPCHICK JOHN · KOPCHICK JOHN J · KOPCHICK JOHN JOSEPH
27 granted patents·16 pending applications·1,585 citations·filing 1984–2025
97Inventor score
Files withUNIV OHIO24ABBOTT LAB5MOLECULAR TECH LABORATORIES LLC4KOPCHICK JOHN J3OHIO UNIVERSITY EDISON BIOTECH3
Top patents by PatentIndex Score
43 records- 0198US5350836AGrowth hormone antagonistsUNIV OHIO·Filed 1992·Granted Sep 27, 1994·800 cites·27 claims
- 0296US6204431B1Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milkABBOTT LAB·Filed 1997·Granted Mar 20, 2001·114 cites·18 claims
- 0396US5891698AOligosaccharides and glycoproteins produced in milk of transgenic non-human mammalsABBOTT LAB·Filed 1995·Granted Apr 6, 1999·120 cites·14 claims
- 0496US5892070ATransgenic non-human mammals producing oligosaccharides and glycoconjugatesABBOTT LAB·Filed 1996·Granted Apr 6, 1999·108 cites·2 claims
- 0596US5700671AMethods of making transgenic animals producing oligosaccharides and glycoproteinsABBOTT LAB·Filed 1995·Granted Dec 23, 1997·98 cites·8 claims
- 0692US5681809AGrowth hormone antagonistsUNIV OHIO·Filed 1994·Granted Oct 28, 1997·53 cites·38 claims
- 0788US4686098AEncapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivoMERCK & CO INC·Filed 1984·Granted Aug 11, 1987·80 cites·3 claims
- 0887US6583115B1Methods for treating acromegaly and giantism with growth hormone antagonistsOHIO UNIVERSITY EDISON BIOTECH·Filed 1995·Granted Jun 24, 2003·53 cites·9 claims
- 0986US7060437B1Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereofUNIV OHIO·Filed 2000·Granted Jun 13, 2006·15 cites·16 claims
- 1085US5750176ATransgenic non-human mammal milk comprising 2'-fucosyl-lactoseABBOTT LAB·Filed 1994·Granted May 12, 1998·55 cites·5 claims
- 1183US11433117B2Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2018·Granted Sep 6, 2022·2 cites·3 claims
- 1281US11473088B2Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock downUNIV OHIO·Filed 2017·Granted Oct 18, 2022·1 cites·23 claims
- 1381US8962811B2Growth hormone and interferon-alpha 2 glycoproteins produced in plantsUNIV OHIO·Filed 2013·Granted Feb 24, 2015·3 cites·20 claims
- 1478US12251421B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2024·Granted Mar 18, 2025·0 cites·12 claims
- 1578US11925674B2Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2022·Granted Mar 12, 2024·0 cites·2 claims
- 1678US2024261369A1Methods for regulating free fatty acid flux using fat specific protein 27 (fsp27) compositionsUNIV OHIO·Filed 2024·Application pending·0 cites
- 1776US11975044B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2022·Granted May 7, 2024·0 cites·3 claims
- 1875US11820804B2Peptide-based inhibitors of growth hormone action and methods of use thereofUNIV OHIO·Filed 2022·Granted Nov 21, 2023·0 cites·17 claims
- 1974US7309572B2Growth hormone-regulatable liver genes and proteins, and uses thereofUNIV OHIO·Filed 2005·Granted Dec 18, 2007·1 cites·18 claims
- 2070US2023002775A1Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock downUNIV OHIO·Filed 2022·Application pending·0 cites
- 2170US2025195610A1Methods for regulating free fatty acid flux using fat specific protein 27 (fsp27) compositionsUNIV OHIO·Filed 2025·Application pending·0 cites
- 2269US5958879AGrowth hormone receptor antagonists and methods of reducing growth hormone activity in a mammalOHIO UNIVERSITY EDISON BIOTECH·Filed 1995·Granted Sep 28, 1999·36 cites·25 claims
- 2368US11426445B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2018·Granted Aug 30, 2022·0 cites·4 claims
- 2468US2023338467A1Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (fsp27) compositionsUNIV OHIO·Filed 2022·Application pending·0 cites
- 2567US2025099550A1Methods for treating alzheimers disease and related dementias and aging using pegylated growth hormone receptor antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2024·Application pending·0 cites
- 2666US6858389B1Growth hormone-regulatable liver genes and proteins, and uses thereofUNIV OHIO·Filed 2000·Granted Feb 22, 2005·1 cites·21 claims
- 2766US2010029548A1Glycoproteins produced in plants and methods of their useUNIV OHIO·Filed 2008·Application pending·0 cites
- 2865US2024082362A1Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2023·Application pending·0 cites
- 2961US4828987AAvian retrovirus-bovine growth hormone DNAMERCK & CO INC·Filed 1984·Granted May 9, 1989·14 cites·5 claims
- 3060US11857602B2Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 3160US11524986B2Peptide-based inhibitors of growth hormone action and methods of use thereofUNIV OHIO·Filed 2019·Granted Dec 13, 2022·0 cites·17 claims
- 3260US6787336B1DNA encoding growth hormone antagonistsOHIO UNIVERSITY EDISON BIOTECH·Filed 1995·Granted Sep 7, 2004·25 cites·50 claims
- 3357US2006148680A1Glycoproteins produced in plants and methods of their useKIELISZEWSKI MARCIA J·Filed 2005·Application pending·0 cites
- 3457US2011230404A1Glycoproteins Produced in Plants and Methods of Their UseUNIV OHIO·Filed 2011·Application pending·0 cites
- 3553US2007111933A1Diagnosis and treatment methods related to aging, especially of liverKOPCHICK JOHN J·Filed 2004·Application pending·0 cites
- 3650US6080911AMice models of growth hormone insensitivityUNIV OHIO·Filed 1997·Granted Jun 27, 2000·6 cites·14 claims
- 3750US2021275633A1Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (fsp27) compositionsUNIV OHIO·Filed 2019·Application pending·0 cites
- 3848US2006240500A1Diagnosis of kidney damage and protection against sameUNIV OHIO·Filed 2003·Application pending·0 cites
- 3947US11452763B2Therapeutic pegylated growth hormone antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2020·Granted Sep 27, 2022·0 cites·7 claims
- 4046US2010028326A1Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serumUNIV OHIO·Filed 2005·Application pending·0 cites
- 4146US2003159164A1Compositions and methods for the synthesis of fatty acids, their derivatives and downstream productsFiled 2002·Application pending·0 cites
- 4245US2011300641A1Protein isoforms for diagnosisKOPCHICK JOHN J·Filed 2009·Application pending·0 cites
- 4343US2007142311A1Diagnosis of hyperinsulinemia and type II diabetes and protection against sameKOPCHICK JOHN J·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John J. Kopchick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →